清热利湿方联合洛索洛芬钠片治疗急性痛风性关节炎的疗效观察及对细胞因子的影响

席雅婧; 康天伦; 王玉天; 刘小平; 朱跃兰

doi:10.3969/j.issn.2095-6606.2021.02.004

您当前的位置：

首页 >

文章列表页 >

清热利湿方联合洛索洛芬钠片治疗急性痛风性关节炎的疗效观察及对细胞因子的影响

临床研究 | 更新时间：2021-05-20

- 清热利湿方联合洛索洛芬钠片治疗急性痛风性关节炎的疗效观察及对细胞因子的影响
- 暂无标题
- 现代中医临床 2021年28卷第2期页码：16-20
- 作者机构：
  
  1.北京中医药大学　　北京100029
  2.北京中医药大学东方医院
- 作者简介：
  
  席雅婧，女，在读硕士生
  #朱跃兰，女，主任医师、教授，博士生导师，E-mail：Zhuyuelangting@163.com
- 基金信息：
  
  北京市科技计划课题(No.Z151100003815013)()
- DOI：10.3969/j.issn.2095-6606.2021.02.004
  中图分类号： R259
- 纸质出版日期：2021-03-30，
  
  收稿日期：2020-09-28，
- 稿件说明：
移动端阅览
席雅婧, 康天伦, 王玉天, 等. 清热利湿方联合洛索洛芬钠片治疗急性痛风性关节炎的疗效观察及对细胞因子的影响[J]. 现代中医临床, 2021,28(2):16-20.
席雅婧, 康天伦, 王玉天, 等. 清热利湿方联合洛索洛芬钠片治疗急性痛风性关节炎的疗效观察及对细胞因子的影响[J]. 现代中医临床, 2021,28(2):16-20. DOI： 10.3969/j.issn.2095-6606.2021.02.004.

DOI：

摘要

目的

观察清热利湿方联合西药洛索洛芬钠片治疗急性痛风性关节炎湿热瘀阻证的疗效及对患者细胞因子的影响。

方法

将92例急性痛风性关节炎湿热瘀阻证患者随机分为治疗组46例、对照组46例。对照组采用洛索洛芬钠片治疗，治疗组在对照组西药治疗基础上联合清热利湿方加减治疗。观察中医证候积分，中医证候疗效，采用视觉模拟评分法(VAS)记录疼痛评分，红细胞沉降率(ESR)、C反应蛋白(CRP)、血白细胞(WBC)、血尿酸(UA)、白介素-1β(IL-1β)、白介素-18(IL-18)、白细胞介素-37(IL-37)，记录不良反应。

结果

2组治疗前后中医证候积分较治疗前均降低(

0.05)，治疗组较对照组降低明显，治疗前后差值比较，差异有统计学意义(

0.05)。治疗组46例中，临床痊愈12例，显效25例，有效6例，无效3例，总有效率为93.48%；对照组46例中，临床痊愈9例，显效23例，有效8例，无效6例，总有效率为86.96%。经秩和检验，

=－1.247，

0.05，说明2组疗效相当。2组治疗后ESR，CRP，WBC，UA，IL-1β，IL-18，VAS评分均较治疗前降低(

0.05)，治疗组较对照组降低明显，治疗前后差值比较，差异均有统计学意义(

0.05)。治疗组不良反应总发生率2.17%，对照组为6.52%。

结论

清热利湿方治疗急性痛风性关节炎湿热瘀阻证可有效减轻炎症反应，改善症状，同时具备良好的安全性。

Abstract

Objective

To observe the efficacy of Qingre Lishi Formula combined with loxoprofen sodium tablets in the treatment of acute gouty arthritis with dampness-heat stasis syndrome and its effects on cytokines.

Methods

Ninety-two patients with acute gouty arthritis with dampness-heat stasis syndrome were randomly assigned to the treatment group (

=46) and the control group (

=46). The control group was treated with loxoprofen sodium tablets

and the treatment group was treated with modified Qingre Lishi Formula in addition to Western medicine in the control group. The scores of TCM syndromes

clinical effects

pain scores

erythrocyte sedimentation rate (ESR)

C-reactive protein (CRP)

leukocyte (WBC)

uric acid (UA)

interleukin-1 β (IL-1 β)

interleukin-18 (IL-18) and interleukin-37 (IL-37) were observed

and the adverse reactions were recorded by visual analogue score (VAS).

Results

The TCM syndrome scores of the two groups were significantly lower after treatment than before treatment (

0.05). The TCM syndrome scores were significantly lower in the treatment group than in the control group (

0.05). There were significant differences between the two groups before and after treatment (

0.05). Among the 46 cases in the treatment group

12 cases were clinically cured

25 cases were markedly effective

6 cases were effective and 3 cases were ineffective with the overall effective rate of 93.48%. Among the 46 cases in the control group

9 cases were clinically cured

23 cases were markedly effective

8 cases were effective and 6 cases were ineffective with the overall effective rate of 86.96%. The rank sum test showed that there was no significant difference in the curative effect between the two groups (

0.05). The scores of ESR

CRP

WBC

IL-1 β

IL-18 and VAS were significantly lower in the two groups after treatment than before treatment

and the scores were significantly lower in the treatment group than in the control group

and there were significant differences between the two groups before and after treatment. The total incidence of adverse reactions was 2.17% in the treatment group and 6.52% in the control group.

Conclusions

Qingre Lishi Formula can effectively reduce inflammatory reactions

improve symptoms and has good safety in the treatment of acute gouty arthritis with dampness-heat and blood stasis syndrome.

关键词

清热利湿方痛风性关节炎IL-1βIL-18IL-37

Keywords

Qingre Lishi Formulagouty arthritisinterleukin-1 β (IL-1 β)interleukin-18 (IL-18)interleukin-37 (IL-37)

references

葛均波，徐永健，王辰.内科学[M].9版.北京：人民卫生出版社，2018:861-864.

罗明辉，刘金文.基于数据挖掘探讨中医药治疗痛风性关节炎用药规律[J].陕西中医，2020,41(9):1320-1323.

陈琳，周静，马武开，等.中医治疗痛风性关节炎的研究进展[J].风湿病与关节炎，2020,9(5):73-76.

左瑞庭，孟庆良，马俊福，等.桂苓甘露饮加减联合秋水仙碱治疗湿热蕴结型痛风性关节炎的临床观察[J].中国实验方剂学杂志，2020,26(16):113-118.

纪慧.非甾体抗炎药的临床应用及不良反应分析[J].中国现代药物应用，2018,12(24):127-128.

王帅.风湿病应用糖皮质激素不良反应的观察[J].北方药学，2019,16(2):177-178.

阎小萍，张煊，翁习生.常见风湿病及相关骨科疾病中西医结合诊治[M].北京：人民卫生出版社，2015:81-91.

甘建平，朱丰林，李延萍，等.清热利湿法治疗急性痛风性关节炎临床疗效的Meta分析[J].风湿病与关节炎，2016,5(9):28-33.

刘美霞，朱桂启，张静雯，等.痹症1号联合依托考昔治疗湿热蕴结型急性痛风性关节炎的临床效果及抗炎机制研究[J].临床医学研究与实践，2020,5(29):145-147.

张冰清，盛峰，谷俊杰，等.《2015年美国风湿病学会/欧洲抗风湿联盟痛风分类标准》摘译[J].中华临床免疫和变态反应杂志，2015,9(4):333-336.

中医病证诊断疗效标准编审委员会. 中医病证诊断疗效标准 [S].南京：南京大学出版社，1994: 31-32.

郑筱萸.中药新药临床研究指导原则(试行)[M].北京：中国医药出版社，2002:179-183.

李茹茹.秋水仙碱联合非布司他治疗痛风性关节炎40例临床观察[J].风湿病与关节炎，2020,9(10):18-19,43.

邹荣鑫，陈勇，刘超波，等.白细胞介素-37与风湿性疾病[J].生命的化学，2017,37(5):849-853.

NOLD M F, NOLD-PETRY C A, ZEPP J A, et al. IL-37 is a fundamental inhibitor of innate immunity[J].Nat Immunol，2010,11(11):1014-1022.

ZENG M, DANG W T, CHEN B F, et al.IL-37 inhibits the production of pro-inflammatory cytokines in MSU crystal-induced inflammatory response[J].Clin Rheumatol，2016,35(9):2251-2258.

LIU L, XUE Y, ZHU Y F et al.Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout[J/OL].Arthritis Res Ther，2016，18: 268(2016-11-18)[2020-09-16].https://doi.org/10.1186/s13075-016-1167-yhttp://doi.org/10.1186/s13075-016-1167-y.

KLUCK V, VAN D R C, CAVALLI G, et al.Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout[J].Ann Rheum Dis，2020,79(4):536-544.

KLEIN-WIERINGA I R, DE LANGE-ROKAAR B J, YUSU E, et al.Inflammatory cells in patients with endstage knee osteoarthritis: a comparison between the synovium and the infrapatellar at pad[J].J Rheumatol，2016,43(4):771-778.

黄继勇，张艳.范永升运用“清热利湿方”治疗急性痛风经验[J].中华中医药杂志，2016,31(1):135-137.

高红勤，朱良春，朱婉华，等.朱良春治疗痛风经验应用体会[J].中国中医药信息杂志，2014,21(8):114-115.

何麒，邵华.邵华教授运用三妙丸治疗痛风的经验[J].中国中医药现代远程教育，2019,17(11):42-44.

南亚婷，照日格图，陈慕芝，等.痛风的中医治疗研究进展[J].风湿病与关节炎，2019,8(12):72-75.

王特，张晓宇，张薇，等.土茯苓防治痛风的作用机制研究进展[J].辽宁中医杂志，2021,48(1):215-217.

谢招虎，解静，李兆福，等.虎杖治疗痛风的作用机制及临床应用研究进展[J].辽宁中医杂志，2019,46(5):1111-1113.

李振彬，马旭，杨静，等.白芍总苷治疗大鼠急性痛风性关节炎的作用及对血清IL-1β、IL-6、TNF-α的影响[J].新医学，2017,48(6):380-384.

曾德浩，闫雪，廖小红，等.非甾体抗炎药的不良反应情况分析与研究[J].中国实用医药，2020,15(24):137-139.

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

自拟清热祛湿止痛方治疗痛风性关节炎复发的临床观察